← SynDRA
BI-2536
SynDRA canonical compound SYN0016325 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PLK1 |
|---|
| Mechanism of action | PLK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PLK inhibitor
- PLK1 INHIBITOR
- Serine/threonine-protein kinase PLK1 inhibitor
Cross-references
Synonyms
- BI 2536
- BI2536
- KIN001-124
- NPK33-1-98-1
- BI2536, BI 2536
- Bi 2536
- 4LJG22T9C6
- RefChem:568032
- Plk1 Inhibitor BI 2536
- DTXCID20148933
- MFCD10565924
- UNII-4LJG22T9C6
- (R)-BI-2536
- NSC755983
- US8598172, 5
- XQVVPGYIWAGRNI-JOCHJYFZSA-N
- C28H39N7O3
- R78
- MLS006011060
- SCHEMBL372489
- GTPL5666
- orb1301011
- SCHEMBL29395966
- BDBM25121
- CHEBI:49868
- BI 2536 [WHO-DD]
- EX-A2350
- FFB03802
- NSC799359
- s1109
- AKOS022179331
- CCG-264824
- CS-0071
- EBC-220032
- EX-8611
- NSC-755983
- NSC-799359
- SDCCGSBI-0654342.P001
- NCGC00253438-01
Look up BI-2536 in the interactive SynDRA portal →